One-day point prevalence of healthcare-associated infections and antimicrobial use in four countries in Latin America

R. Huerta-Gutiérrez, L. Braga, A. Camacho-Ortiz, Humberto Díaz-Ponce, L. García-Mollinedo, M. Guzmán-Blanco, S. Valderrama-Beltrán, E. Landaeta-Nezer, S. Moreno-Espinosa, Rayo Morfín-Otero, P. Rodríguez-Zulueta, A. Rosado-Buzzo, Fernando Rosso-Suárez, W. Trindade-Clemente, Denusa Wiltgen

Producción: Contribución a una revistaArtículorevisión exhaustiva

34 Citas (Scopus)

Resumen

Background and aims: Experience in the region shows that in some countries there is very good surveillance of Healthcare-associated infections (HAIs) in health services, but there is no national data consistently in all countries. Therefore, we set to estimate the total burden of HAIs and antimicrobial use in acute care hospitals in Brazil, Venezuela, Mexico, and Colombia using the one-day point prevalence methodology. Methods: The survey was conducted between June and July 2016. In each ward or unit, HAIs and antimicrobial use data were collected on a single day by a trained team of researchers. Also, for each patient, we collected data on risk factors for infections. Results: One out of ten individuals surveyed had at least one healthcare-associated infection (HAI). Pneumonia and surgical site infections were the most relevant among the surveyed countries. Most of the surveyed participants, regardless of their HAI status, received antibiotics except the individuals managed in Brazil. Carbapenems and third-generation Cephalosporins were among the most frequently used antibiotics. Conclusion: Our results add to WHO's recent efforts to understand HAIs prevalence and antibiotic consumption in low and middle-income countries, of which we studied three that were not included in their last report.

Idioma originalInglés
Páginas (desde-hasta)157-166
Número de páginas10
PublicaciónInternational Journal of Infectious Diseases
Volumen86
DOI
EstadoPublicada - sep. 2019

Huella

Profundice en los temas de investigación de 'One-day point prevalence of healthcare-associated infections and antimicrobial use in four countries in Latin America'. En conjunto forman una huella única.

Citar esto